The status of serum γ-interferonand antiviral antibodies in patients with type I and type 2 diabetes: A comparative study

Journal of Research in Medical Sciences

Volumn 17, Issue 9, 2012, Pages 855-858

  Dezayee, Zhian M I ^a  

^a HAWLER MEDICAL UNIVERSITY   (Iraq)

Author keywords

Diabetes; Glycemic control; Virus

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; VIRUS ANTIBODY;

ADULT; ARTICLE; BLOOD ANALYSIS; COXSACKIE VIRUS; COXSACKIE VIRUS INFECTION; CROSS-SECTIONAL STUDY; CYTOMEGALOVIRUS; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCEMIC CONTROL; HUMAN; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RUBELLA VIRUS;

EID: 84869406619     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Van der WN, KroeseFG, Rozing J, Hillebrands JL. Viral infections as potential triggers of type 1 diabetes. Diabetes Metab Res Rev 2007;23:169-83.
2. Honeyman M. How robust is the evidence for viruses in the induction of type 1 diabetes? CurrOpinImmunol2005;17:616-23.
3. Coppieters KT, Wiberg A, Tracy SM, vonHerrath MG. Immunology in the clinic review series: Focus on type 1 diabetes and viruses: The role of viruses in type 1 diabetes: A difficult dilemma. ClinExpImmunol 2012;168:5-11.
4. Sané F, Moumna I, Hober D. Group B coxsackieviruses and autoimmunity: Focus on Type 1 diabetes. Expert Rev ClinImmunol 2011;7:357-66.
5. Haverkos HW, Battula N, Drotman DP, Rennert OM. Enteroviruses and type 1 diabetes mellitus. Biomed Pharmacother2003;57:379-85.
6. Robles DT, Eisenbarth GS. Type 1A diabetes induced by infection and immunization. J Autoimmun2001;16:355-62.
7. Rossini AA. Autoimmune diabetes and the circle of tolerance. Diabetes2004;53:267-75.
8. Liu JL, Chen JY, Chen CT, Wang JH, Lin CY, Chen PF, et al. A community-based cross-sectional study: The association of lipids with hepatitis C seropositivity and diabetes mellitus. J GastroenterolHepatol 2012.
9. Balogun WO, Adeleye JO, Akinlade KS, Kuti M, Otegbayo JA. Low prevalence of hepatitis-C viral seropositivity among patients with type-2 diabetes mellitus in a tertiary hospital. J Natl Med Assoc 2006;98:1805-8.
10. SERION ELISA classic. CoxsackievirusIgA/IgG/IgM. Available from: http://www.virion-serion.de/uploads/mit_download/Coxsackievirus.
11. Lammi N, Karvonen M, Tuomilehto J. Do microbes have a causal role in type 1 diabetes? Med SciMonit 2005;11:63-9.
12. Li Q, Xing H, Zhou Y, Qiu LL, Zhang ZW, Liao L. Association of coxsackievirus infection and T lymphocyte subset changes with type 1 diabetes. Nan Fang Yi Ke Da XueXueBao 2010;30:2699-701.
13. Karjalainen J, Knip M, Hyoty H, Linikki P, Ilonen J, AkerblomHK, et al. Relationship between serum insulin antibodies, islet cell antibodies and Coxsackie-B4 and mumps virus-specific antibodies at the clinical manifestation of type 1 (insulin-dependent) diabetes. Diabetologia 1988;31:146-52.
14. Akatsuka H, Yano Y, Gabazza EC, Morser J, Sasaki R, Suzuki T, et al. A case of fulminant type 1 diabetes with coxsackieB4 virus infection diagnosed by elevated serum levels of neutralizing antibody. Diabetes Res ClinPract 2009;84:e50-2.
15. HorwitzMS, Bradley LM, Harbertson J, Krahl T, Lee J, SarvetnickN. Diabetes induced by coxsackie virus: Initiation by bystander damage and not molecular mimicry. Nat Med 1998;4:781-5.
16. Serreze DV, Wasserfall C, Ottendorfer EW, Stalvey M, Pierce MA, Gauntt C, et al. Diabetes acceleration or prevention by a Coxsackievirus B4 infection: Critical requirements for both interleukin-4 and gamma interferon. JVirol2005;79:1045-52.
17. Filippi CM, Estes EA, Oldham JE, von Herrath MG. Immunoregulatory mechanisms triggered by viral infections protect from type 1 diabetes in mice. J Clin Invest2009;119:1515-23.